Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Efficiently emulating computer architecture condition code settings without executing branch instructions
Holding structure for a touch panel
System and method for video encoding
Interleaving charge pumps for programmable memories
Drug delivery system
Stable liquid VEGF antagonist formulations
Methods and apparatus for voltage selection for a MOSFET switch device
  Randomly Featured Patents
Remote activation of a chemiluminescent lightstick
Pulse generating circuit and UWB communication system
Waterproof panel
Solar oven
Methods for inhibiting tumor cell growth
Sheet processing apparatus
Suspension system for vehicle
7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
Explosively activated impact switch with interlocking contacts
Method and apparatus for detecting prime mover start malfunction